The U.S. Food and Drug Administration approved Zycubo (copper histidinate) injection as the first treatment for Menkes disease in pediatric ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE